Shrujal Baxi

Shrujal Baxi has an extensive work experience in the medical field. Shrujal is currently serving as the Chief Medical Officer at Iterative Health since September 2022. Before this role, they held the position of the SVP, Clinical and Scientific Solutions at Verana Health from August 2021 to September 2022. Prior to that, Shrujal worked at Flatiron Health, where they served as the Head of Clinical Science from February 2020 to August 2021, and as the Senior Medical Director from January 2018 to August 2021. Shrujal also has experience as an Adjunct Assistant Professor at New York University from April 2019 to June 2020. Furthermore, they have worked at Memorial Sloan Kettering Cancer Center as a Medical Oncologist from July 2011 to January 2018, and as a Medical Oncology Fellow from July 2008 to June 2011. Additionally, Shrujal worked at New York University as the Chief Resident-Internal Medicine from July 2007 to June 2008, and as a Resident in Internal Medicine from July 2004 to June 2007.

Shrujal Baxi completed a Bachelor of Arts degree in Political Science and Government from the University of Illinois Chicago from 1997 to 2000. From 2000 to 2004, Shrujal pursued a Master of Public Health (MPH) degree in Health Policy and Administration and a Doctor of Medicine (MD) degree, both from the University of Illinois Chicago.